ezetimibe has been researched along with ro 48-8071 in 1 studies
Studies (ezetimibe) | Trials (ezetimibe) | Recent Studies (post-2010) (ezetimibe) | Studies (ro 48-8071) | Trials (ro 48-8071) | Recent Studies (post-2010) (ro 48-8071) |
---|---|---|---|---|---|
2,484 | 563 | 1,465 | 32 | 0 | 14 |
Protein | Taxonomy | ezetimibe (IC50) | ro 48-8071 (IC50) |
---|---|---|---|
Squalene--hopene cyclase | Alicyclobacillus acidocaldarius subsp. acidocaldarius DSM 446 | 0.06 | |
Lanosterol synthase | Homo sapiens (human) | 0.0793 | |
Fatty-acid amide hydrolase 1 | Rattus norvegicus (Norway rat) | 0.0065 | |
Monoglyceride lipase | Rattus norvegicus (Norway rat) | 0.0065 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chuang, JC; Lopez, AM; Posey, KS; Repa, JJ; Turley, SD; Valasek, MA | 1 |
1 other study(ies) available for ezetimibe and ro 48-8071
Article | Year |
---|---|
Sustained and selective suppression of intestinal cholesterol synthesis by Ro 48-8071, an inhibitor of 2,3-oxidosqualene:lanosterol cyclase, in the BALB/c mouse.
Topics: Animals; Azetidines; Benzophenones; Cholesterol; Diet; Ezetimibe; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intestinal Mucosa; Intestine, Small; Intramolecular Transferases; Liver; Male; Mesocricetus; Mice; Mice, Inbred BALB C; Receptors, LDL; Simvastatin; Species Specificity | 2014 |